Pandion Therapeutics

📍 Cambridge, United States🗓 Founded 2016👥 41 employees💰 Last funded Jul 2018
Biotechnology🌐 pandiontx.com
Website LinkedIn
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants. Our localized approach represents a significant change from the systemic immunosuppression of conventional medicines, which often have dose-limiting safety concerns and can cause serious infections and cancer. Furthermore, through tissue-specific therapeutic targeting, Pandion’s approach has the potential to more effectively induce and sustain response and remission in patients with many autoimmune and inflammatory conditions. We aim to shift the paradigm and create a new generation of drugs with transformative efficacy and improved safety.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Pandion Therapeutics?
Pandion Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Pandion Therapeutics last raise funding?
The most recent investment in Pandion Therapeutics recorded on gritt.io was in July 2018.
When was Pandion Therapeutics founded?
Pandion Therapeutics was founded in 2016.
What industry is Pandion Therapeutics in?
Pandion Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Pandion Therapeutics based?
Pandion Therapeutics is headquartered in Cambridge, United States.